BECOTATUG VEDOTIN
Clinical trials for BECOTATUG VEDOTIN explained in plain language.
Never miss a new study
Get alerted when new BECOTATUG VEDOTIN trials appear
Sign up with your email to follow new studies for BECOTATUG VEDOTIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted drug combo aims to tackle tough stomach cancers
Disease control Not yet recruitingThis phase 2 trial tests a combination of two drugs—becotatugvedotin (a targeted therapy that delivers a toxin directly to cancer cells) and pucotenlimab (an immunotherapy that helps the immune system attack cancer)—as a second-line treatment for people with advanced gastric or g…
Matched conditions: BECOTATUG VEDOTIN
Phase: PHASE2 • Sponsor: West China Second University Hospital • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New triple therapy hopes to outsmart tough esophageal cancer
Disease control Not yet recruitingThis study tests a new combination of three drugs—becotatug vedotin, tislelizumab, and chemotherapy—for people with advanced esophageal squamous cell carcinoma (ESCC) who have not had prior treatment. The goal is to see if adding the targeted drug becotatug vedotin to standard im…
Matched conditions: BECOTATUG VEDOTIN
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC